drugset / Trial / NCT01027234

This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses

NCT01027234 ↗

Phase 1 Terminated 40 enrolled AstraZeneca
RandomizedSingle-groupDouble-blindBasic science

Summary

The main purpose of this study is to assess the safety and tolerability of AZD8418 after single increasing oral doses. Another purpose of this study is to evaluate the pharmacokinetics (also called PK - how the study drug enters and leaves the body and how your body acts on the study drug) of AZD8418. Part B of the study will assess the effect of food on the safety and pharmacokinetics of AZD8418.

Timeline

Start
2009-11
Primary completion
2010-03
Completion
2010-03

Outcome

Outcome not reported

Stopped: “Pre-Clinical Safety Tox Findings”

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8418 Small molecule — Oral

Indications

No indication recorded.